日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial

口服铁剂补充对射血分数降低且伴有缺铁的心力衰竭患者运动能力的影响:IRONOUT HF随机临床试验

Lewis, Gregory D; Malhotra, Rajeev; Hernandez, Adrian F; McNulty, Steven E; Smith, Andrew; Felker, G Michael; Tang, W H Wilson; LaRue, Shane J; Redfield, Margaret M; Semigran, Marc J; Givertz, Michael M; Van Buren, Peter; Whellan, David; Anstrom, Kevin J; Shah, Monica R; Desvigne-Nickens, Patrice; Butler, Javed; Braunwald, Eugene

Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure

ATHENA-HF试验的原理和设计:醛固酮靶向神经激素联合利钠疗法治疗心力衰竭

Butler, Javed; Hernandez, Adrian F; Anstrom, Kevin J; Kalogeropoulos, Andreas; Redfield, Margaret M; Konstam, Marvin A; Tang, W H Wilson; Felker, G Michael; Shah, Monica R; Braunwald, Eugene

Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure

口服铁剂治疗射血分数降低的心力衰竭:口服铁剂补充对心力衰竭患者氧摄取的影响及其设计和原理

Lewis, Gregory D; Semigran, Marc J; Givertz, Michael M; Malhotra, Rajeev; Anstrom, Kevin J; Hernandez, Adrian F; Shah, Monica R; Braunwald, Eugene

Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.

黄嘌呤氧化酶抑制剂对高尿酸血症心力衰竭患者的影响:黄嘌呤氧化酶抑制剂治疗高尿酸血症心力衰竭患者(EXACT-HF)研究

Givertz Michael M, Anstrom Kevin J, Redfield Margaret M, Deswal Anita, Haddad Haissam, Butler Javed, Tang W H Wilson, Dunlap Mark E, LeWinter Martin M, Mann Douglas L, Felker G Michael, O'Connor Christopher M, Goldsmith Steven R, Ofili Elizabeth O, Saltzberg Mitchell T, Margulies Kenneth B, Cappola Thomas P, Konstam Marvin A, Semigran Marc J, McNulty Steven E, Lee Kerry L, Shah Monica R, Hernandez Adrian F

Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease

促进高影响力艾滋病毒相关心血管研究:美国国家心肺血液研究所艾滋病毒相关心脏、肺和血液疾病多学科工作组的建议

Shah, Monica R; Cook, Nakela; Wong, Renee; Hsue, Priscilla; Ridker, Paul; Currier, Judith; Shurin, Susan

Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions

全球心力衰竭住院患者临床试验的试验地点选择:面临的问题和潜在解决方案

Gheorghiade, Mihai; Vaduganathan, Muthiah; Greene, Stephen J; Mentz, Robert J; Adams, Kirkwood F Jr; Anker, Stefan D; Arnold, Malcolm; Baschiera, Fabio; Cleland, John G F; Cotter, Gadi; Fonarow, Gregg C; Giordano, Christopher; Metra, Marco; Misselwitz, Frank; Mühlhofer, Eva; Nodari, Savina; Frank Peacock, W; Pieske, Burkert M; Sabbah, Hani N; Sato, Naoki; Shah, Monica R; Stockbridge, Norman L; Teerlink, John R; van Veldhuisen, Dirk J; Zalewski, Andrew; Zannad, Faiez; Butler, Javed

Heart transplantation research in the next decade--a goal to achieving evidence-based outcomes: National Heart, Lung, And Blood Institute Working Group

未来十年心脏移植研究——以循证医学成果为目标:美国国家心肺血液研究所工作组

Shah, Monica R; Starling, Randall C; Schwartz Longacre, Lisa; Mehra, Mandeep R

High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomization

ESCAPE研究未纳入患者死亡率高:接受肺动脉导管治疗但未进行随机分组的心力衰竭患者登记研究

Allen, Larry A; Rogers, Joseph G; Warnica, J Wayne; Disalvo, Thomas G; Tasissa, Gudaye; Binanay, Cynthia; O'Connor, Christopher M; Califf, Robert M; Leier, Carl V; Shah, Monica R; Stevenson, Lynne W

Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial

袢利尿剂剂量与心力衰竭患者预后的关系:ESCAPE试验结果

Hasselblad, Vic; Gattis Stough, Wendy; Shah, Monica R; Lokhnygina, Yuliya; O'Connor, Christopher M; Califf, Robert M; Adams, Kirkwood F Jr